CELZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CELZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-05-29), Creative Medical Technology Holdings's current share price is $1.96. Creative Medical Technology Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $58.69. Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio for today is 0.03.
The historical rank and industry rank for Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Creative Medical Technology Holdings's highest Cyclically Adjusted PS Ratio was 1261.53. The lowest was 0.03. And the median was 0.30.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Creative Medical Technology Holdings's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $58.69 for the trailing ten years ended in Mar. 2025.
The historical data trend for Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Medical Technology Holdings Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
1.52 | 0.28 | 0.05 | 0.07 | 0.04 |
Creative Medical Technology Holdings Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | 0.06 | - | 0.04 | 0.04 |
For the Biotechnology subindustry, Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 1.96 | / | 58.69 | |
= | 0.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Medical Technology Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:
For example, Creative Medical Technology Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Mar. 2025 (Change) | * | Current CPI (Mar. 2025) |
= | 0.002 | / | 134.9266 | * | 134.9266 | |
= | 0.002 |
Current CPI (Mar. 2025) = 134.9266.
Creative Medical Technology Holdings Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.000 | 100.392 | 0.000 |
201512 | 0.000 | 99.792 | 0.000 |
201603 | 0.000 | 100.470 | 0.000 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.000 | 101.861 | 0.000 |
201612 | 0.000 | 101.863 | 0.000 |
201703 | 0.000 | 102.862 | 0.000 |
201706 | 0.000 | 103.349 | 0.000 |
201709 | 0.000 | 104.136 | 0.000 |
201712 | 0.000 | 104.011 | 0.000 |
201803 | 10.000 | 105.290 | 12.815 |
201806 | 5.000 | 106.317 | 6.345 |
201809 | 52.000 | 106.507 | 65.876 |
201812 | 58.000 | 105.998 | 73.829 |
201903 | 51.000 | 107.251 | 64.161 |
201906 | 62.000 | 108.070 | 77.408 |
201909 | 29.000 | 108.329 | 36.120 |
201912 | -1.000 | 108.420 | -1.244 |
202003 | 0.271 | 108.902 | 0.336 |
202006 | 0.824 | 108.767 | 1.022 |
202009 | 0.282 | 109.815 | 0.346 |
202012 | 0.117 | 109.897 | 0.144 |
202103 | 0.000 | 111.754 | 0.000 |
202106 | 0.043 | 114.631 | 0.051 |
202109 | 0.041 | 115.734 | 0.048 |
202112 | 0.107 | 117.630 | 0.123 |
202203 | 0.023 | 121.301 | 0.026 |
202206 | 0.000 | 125.017 | 0.000 |
202209 | 0.039 | 125.227 | 0.042 |
202212 | 0.013 | 125.222 | 0.014 |
202303 | 0.000 | 127.348 | 0.000 |
202306 | 0.000 | 128.729 | 0.000 |
202309 | 0.004 | 129.860 | 0.004 |
202312 | 0.002 | 129.419 | 0.002 |
202403 | 0.000 | 131.776 | 0.000 |
202406 | 0.006 | 132.554 | 0.006 |
202409 | 0.000 | 133.029 | 0.000 |
202412 | 0.002 | 133.157 | 0.002 |
202503 | 0.002 | 134.927 | 0.002 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Creative Medical Technology Holdings (NAS:CELZ) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael H. Finger | director | 1551 N. DIANE ST., MESA AZ 85203-3850 |
Timothy Warbington | director, 10 percent owner, officer: President & CEO | 211 E. OSBORN ROAD, PHOENIX AZ 85012 |
Susan H Snow | director | 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926 |
Bruce Steven Urdang | director | 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377 |
Thomas Ichim | director | 211 E. OSBORN RD, PHOENIX AZ 85012 |
Creative Medical Health Inc. | 10 percent owner | 211 E. OSBORN RD, PHOENIX AZ 85012 |
Timothy Herbst | 10 percent owner | 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029 |
Amit Nilkanth Patel | director | 1040 CHARTWELL CT., SALT LAKE CITY UT 84121 |
Donald Dickerson | director, officer: CFO & Sr.VP | 822 VERA STREET, SOLANA BEACH CA 92075 |
Steven L White | director, officer: President,Secretary,Treasurer | 386 NORTH 210 EAST, MAPLETON UT 84664 |
From GuruFocus
By Business Wire • 03-27-2024
By PRNewswire • 06-28-2023
By Marketwired • 01-30-2025
By PRNewswire PRNewswire • 06-09-2023
By PRNewswire PRNewswire • 04-12-2023
By PRNewswire PRNewswire • 03-23-2023
By PRNewswire PRNewswire • 06-12-2023
By PRNewswire PRNewswire • 05-22-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.